Skip to main content

Cepheid Wins US Patent for I-CORE Tech

NEW YORK, June 20 -Cepheid said today it had won a patent in the US for a reaction vessel to its I-CORE DNA amplification and detection technology.

 

The patent, No. 6,403,037, covers a technology that allows genetic material to be handled automatically. According to Cepheid, the vessel "can be filled with reaction fluid and sealed using conventional high-throughput pipetting equipment."

 

Click here for more information.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.